We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$1.46B
AUM Growth
+$222M
Cap. Flow
+$49.8M
Cap. Flow %
3.4%
Top 10 Hldgs %
67.23%
Holding
266
New
5
Increased
172
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$167M
2
AMZN icon
Amazon
AMZN
+$5.51M
3
ABT icon
Abbott
ABT
+$4.26M
4
AGN
Allergan plc
AGN
+$2.31M
5
XYZ
Block Inc
XYZ
+$2.26M

Sector Composition

Rank Sector Weight
1 Healthcare 58.41%
2 Energy 12.88%
3 Utilities 5.3%
4 Consumer Staples 4.25%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDRL
251
DELISTED
Seadrill Limited Common Stock
SDRL
$4K ﹤0.01%
4
CAPNW
252
DELISTED
Capnia, Inc. Series A Warrant
CAPNW
$2K ﹤0.01%
10,985
CRC
253
DELISTED
California Resources Corporation
CRC
$2K ﹤0.01%
123
-17
-12% -$270
DHC
254
Diversified Healthcare Trust
DHC
$2.17B
$1K ﹤0.01%
68
CST
255
DELISTED
CST Brands, Inc.
CST
$1K ﹤0.01%
33
BAX icon
256
Baxter International
BAX
$13.8B
-7,858
Closed -$323K
FCX icon
257
Freeport-McMoran
FCX
$91.2B
$0 ﹤0.01%
44
RYAM icon
258
Rayonier Advanced Materials
RYAM
$604M
$0 ﹤0.01%
1
UUUU icon
259
Energy Fuels
UUUU
$2.93B
$0 ﹤0.01%
1
MRO
260
DELISTED
Marathon Oil Corporation
MRO
-2,316
Closed -$26K
FIT
261
DELISTED
Fitbit, Inc. Class A common stock
FIT
-13,818
Closed -$209K
AET
262
DELISTED
Aetna Inc
AET
-2,013
Closed -$226K
BXLT
263
DELISTED
BAXALTA INC COM STK (DE)
BXLT
-7,752
Closed -$313K
ADT
264
DELISTED
ADT Corp
ADT
-22,171
Closed -$915K
RNF
265
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
-1,452
Closed -$17K

Similar funds

Bollard Group's Q2 2016 Portfolio in Review

As of Q2 2016, Bollard Group held 266 positions worth $1.46B, up 18% from $1.24B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bollard Group deployed $49.8M of net new capital in Q2 2016, opening 5 new positions and adding to 172 existing holdings. Its largest new stake was Allergan plc: 10,000 shares worth $2.31M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 44% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $1.73M trimmed.

  • Bollard Group's largest Q2 2016 buy was Allergan plc: 10,000 shares worth $2.31M.
  • Bollard Group added most to Boston Scientific in Q2 2016, an estimated $167M increase.
  • Bollard Group's biggest Q2 2016 reduction was ProShares Short S&P500, cutting an estimated $1.73M.
  • Bollard Group fully exited ADT Corp in Q2 2016, selling an estimated $915K.
  • Bollard Group's ten largest holdings make up 67% of its $1.46B portfolio in Q2 2016.
  • Bollard Group opened 5 new positions and closed 8 in Q2 2016.
  • Bollard Group's portfolio value rose 18% quarter-over-quarter to $1.46B.

Based on Bollard Group's 13F filing for Q2 2016, filed 20 Jul 2016.